PLANET LABS PBC (PL)

US72703X1063 - Common Stock

2.39  +0.1 (+4.37%)

Premarket: 2.36 -0.03 (-1.26%)

Fundamental Rating

4

Overall PL gets a fundamental rating of 4 out of 10. We evaluated PL against 80 industry peers in the Professional Services industry. PL has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PL is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year PL has reported negative net income.
PL had a negative operating cash flow in the past year.
In the past 5 years PL always reported negative net income.
In the past 5 years PL always reported negative operating cash flow.

1.2 Ratios

PL has a Return On Assets of -20.07%. This is amonst the worse of the industry: PL underperforms 81.25% of its industry peers.
The Return On Equity of PL (-27.06%) is worse than 80.00% of its industry peers.
Industry RankSector Rank
ROA -20.07%
ROE -27.06%
ROIC N/A
ROA(3y)-19.41%
ROA(5y)-24.83%
ROE(3y)-25.47%
ROE(5y)-50.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 51.36%, PL is in the better half of the industry, outperforming 61.25% of the companies in the same industry.
In the last couple of years the Gross Margin of PL has grown nicely.
PL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.27%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PL has been increased compared to 1 year ago.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 0.09, we must say that PL is in the distress zone and has some risk of bankruptcy.
PL has a worse Altman-Z score (0.09) than 80.00% of its industry peers.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACC8.92%

2.3 Liquidity

PL has a Current Ratio of 2.74. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
PL's Current ratio of 2.74 is amongst the best of the industry. PL outperforms 83.75% of its industry peers.
A Quick Ratio of 2.74 indicates that PL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.74, PL belongs to the best of the industry, outperforming 83.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.74

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.65% over the past year.
PL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.07%.
PL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.93% yearly.
EPS 1Y (TTM)59.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.54%
Revenue 1Y (TTM)12.07%
Revenue growth 3Y24.93%
Revenue growth 5YN/A
Sales Q2Q%14.68%

3.2 Future

Based on estimates for the next years, PL will show a very strong growth in Earnings Per Share. The EPS will grow by 25.87% on average per year.
PL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.18% yearly.
EPS Next Y28.8%
EPS Next 2Y26.39%
EPS Next 3Y25.87%
EPS Next 5YN/A
Revenue Next Year16.25%
Revenue Next 2Y17.58%
Revenue Next 3Y19.18%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

PL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 25.87% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.39%
EPS Next 3Y25.87%

0

5. Dividend

5.1 Amount

No dividends for PL!.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (7/25/2024, 7:06:38 PM)

Premarket: 2.36 -0.03 (-1.26%)

2.39

+0.1 (+4.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap694.94M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.07%
ROE -27.06%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 51.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.74
Quick Ratio 2.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)59.65%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y28.8%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.07%
Revenue growth 3Y24.93%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y